Stability Biologics, LLC - Fair Value of Stock Consideration for Acquisition (Details) - USD ($)	Jan. 13, 2016	Jan. 01, 2015
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Marketability discount (percent)	10.00%
Fair Value of Equity Consideration Transferred	$ 3,347,000
Stability Biologics, LLC
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Common Share Price at Closing on 1/13/2016 ($ per share)	$ 8.43
Multiplied by: Number of Common Shares Transferred to the Sellers	441,009.000	441,009
Indicated Value of Equity Consideration (on a Freely Tradable Interest Basis)	$ 3,718,000
Less: Marketability Discount @ 10%	(371,000)
Fair Value of Equity Consideration Transferred	$ 3,347,000

Business Acquisition, Equity Interest Issued or Issuable, Value Assigned, Gross

No definition available.

Name:	mdxg_BusinessAcquisitionEquityInterestIssuedorIssuableValueAssignedGross
Namespace Prefix:	mdxg_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Business Acquisition, Equity Interest Issued or Issuable, Value Assigned, Marketability Discount

+ References

No definition available.

+ Details

Name:	mdxg_BusinessAcquisitionEquityInterestIssuedorIssuableValueAssignedMarketabilityDiscount
Namespace Prefix:	mdxg_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Business Acquisition, Equity Interest Issued or Issuable, Value Assigned, Marketability Discount, Percent

+ References

No definition available.

+ Details

Name:	mdxg_BusinessAcquisitionEquityInterestIssuedorIssuableValueAssignedMarketabilityDiscountPercent
Namespace Prefix:	mdxg_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)(4)
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479

+ Details

Name:	us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Number of shares of equity interests issued or issuable to acquire entity.

+ References

+ Details

Name:	us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.

+ References

No definition available.

+ Details

Name:	us-gaap_BusinessAcquisitionSharePrice
Namespace Prefix:	us-gaap_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_BusinessAcquisitionAxis=mdxg_StabilityBiologicsLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: